Stay updated on Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial

Sign up to get notified when there's something new on the Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    0.5%
    Check dated 2026-10-26T23:02:42.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-19T23:23:21.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-13T05:31:34.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The label for finding contact information was updated from 'Find Contact Information' to 'Find contact information', standardizing capitalization. The revision tag was updated from 'Revision: v3.6.6' to 'Revision: v3.7.0', reflecting a newer page version in the history.
    Difference
    0.2%
    Check dated 2026-09-21T23:47:42.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    A new Study Status entry has been added to the Study Record History, and the latest version is labeled 27, reflecting the study's current state within the version history.
    Difference
    0.3%
    Check dated 2026-09-07T22:55:03.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    A new revision entry, v3.6.6, was added to the record history, replacing the previous revision v3.6.5. This update reflects an adjustment to the history metadata rather than substantive content changes.
    Difference
    0.1%
    Check dated 2026-08-31T18:57:19.000Z thumbnail image

Stay in the know with updates to Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial page.